Alembic Pharma gets Final Approval for Glycopyrrolate Injection USP from its General Sterile Facility
Alembic Pharmaceuticals Ltd today announced that it has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application for Glycopyrrolate Injection.
Source: equitybulls.com